InvestorInvesting in the future of life sciences and technology.
MIG Capital
MIG Capital is a Munich-based venture capital firm that invests in early-stage companies in the life sciences and deep tech sectors across Europe. Founded in 2004, it has a unique funding model supported by over 60,000 private retail investors.
Online destinations
Find MIG Capital online
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Official links
Pages the organization runs itself.
Overview
MIG Capital is a venture capital firm founded in 2004 and based in Munich, Germany. The organization focuses on supporting founders in the deep tech and life sciences sectors, providing not only capital but also personal support and a network to help develop innovative companies. With a commitment of over €1.2 billion from more than 60,000 private retail investors, MIG Capital has established itself as one of Germany's leading VC investors. The firm has invested over €680 million in approximately 50 companies, including notable successes like BioNTech, which developed the first approved COVID-19 mRNA vaccine. MIG Capital's investment strategy emphasizes long-term growth and innovation in technology and healthcare.
Focus
MIG Capital invests primarily in deep tech and life sciences. In deep tech, the firm focuses on advanced computing, digitalization & IoT, energy & environment, and new materials. In life sciences, it covers bio-pharmaceutical therapeutics, medical technology, and digital health. The firm typically invests between €1 million and €10 million, with a sweet spot around €3 million to €5 million.
Support
MIG Capital adds value to its portfolio companies by providing not just financial investment but also personal support and access to a vast network of industry contacts. This approach helps companies navigate challenges and accelerate their growth.
Questions
What are MIG Capital's investment criteria?
MIG Capital focuses on seed-stage investments in deep tech and life sciences sectors. They typically invest between €1 million and €10 million, with a preference for amounts around €3 million to €5 million. The firm looks for innovative companies that are developing breakthrough technologies.
How can founders apply or pitch to MIG Capital?
Founders can pitch their ideas through the MIG Capital website at mig.ag. It is advisable to include a detailed business plan and financial projections in the pitch deck.
What makes MIG Capital different from other venture capital firms?
MIG Capital is unique as it is funded entirely by over 60,000 private retail investors, allowing for a long-term investment horizon without the pressure of institutional LPs. This model enables the firm to provide not just capital but also personal support and access to a vast network.
What is the geographic scope of MIG Capital's investments?
The firm primarily invests in Europe, focusing on innovative companies within the deep tech and life sciences sectors.
What is MIG Capital's post-investment involvement like?
MIG Capital provides ongoing support to its portfolio companies, including mentorship, operational assistance, and access to its extensive network of industry contacts. This support helps companies navigate challenges and accelerate their growth.
What is the size of MIG Capital's funds?
MIG Capital has committed over €1.2 billion across multiple funds, with a total invested amount exceeding €680 million in approximately 50 companies.
Check your startup’s fit
Check your startup’s fit with MIG CapitalSimilar investors
Organizations that do similar work to MIG Capital.
Investor
InvestorHuman Capital is a multi-stage venture capital firm that partners with exceptional founders to build companies addressing critical industry challenges. They focus on assembling high-caliber teams and deploying capital to support these ventures.
InvestorOrbiMed is a healthcare-focused investment firm based in New York City, managing approximately $19 billion in assets. The firm invests across the healthcare spectrum, from early-stage startups to large multinational companies, with a focus on biopharmaceuticals and medical technologies.
InvestorSV Health Investors is a healthcare-focused venture capital and growth equity firm based in Boston and London. With over 30 years of experience, it specializes in investing across various healthcare sectors, including biotechnology and medtech.
Superscout Pro
Find faster. Show up verified. Keep your deals private.
$99a year, or $12 a month
Get Pro- Search that narrowsInvestors, programs, accelerators, incubators and studios, by stage, sector and place.
- A verified profileThe people you reach know you are who you say you are.
- A private deal vaultThe startups you are watching, with your notes and your reasons. Nobody else's eyes.
Is this page right?Reviewed · How the research works